Step 5 of 12: GTM Strategy and Commercial Infrastructure

The Part Where Enthusiasm Meets Reality and Reality Wins

A pitch deck.

A sales rep you hired three weeks ago.

A pricing slide that got thrown together the night before a board meeting.

A VP of Commercial who starts next month.

A shiny new logo the leadership team spent four months arguing about.

And, naturally, a LinkedIn post announcing your FDA clearance with enough fire emojis to trigger a smoke alarm.

Congratulations. According to a shocking number of MedTech startups, you now have a go-to-market strategy.

You do not. What you have is a pile of commercial activities connected by optimism and the belief that momentum will somehow organize itself into revenue.

It won't.

This is Step 5 of the recovery program: GTM strategy and commercial infrastructure.

The point where we stop talking about commercialization and start talking about how products actually get sold.

GTM Strategy Isn't Marketing. It Isn't Sales. It's The System.

Most founders think GTM means hiring a salesperson.

Some think it means creating a brand.

A few think it's buying Salesforce.

None of those things are a strategy.

A real GTM strategy answers three questions:

1. How do we sell?

   What's the value story? What's the pricing model? How do we handle objections? How does a deal actually move from interest to contract?
   

2. Who do we sell to first?

   Not everyone. Not someday. First.

   Which accounts matter most? Which customers create momentum? Which ones create proof?
   

3. How do we do it consistently?

   Process. Roles. Communication. Accountability.

   Because if every deal depends on heroics, you don't have a commercial engine. You have a collection of lucky accidents.

Everything else is decoration.

And most early-stage MedTech companies spend an incredible amount of time decorating.

Your First Customers Are More Important Than You Think

Everyone talks about finding early adopters.

Very few people think carefully about which early adopters.

Your first few accounts don't just generate revenue.

They become your identity.

They tell the market who you serve, where you fit, and whether anyone should take you seriously.

Sometimes your ideal customer isn't actually your first customer.

I know. Startup gurus everywhere are clutching their LinkedIn thought leadership posts. But healthcare adoption doesn't happen in a vacuum.

If your ideal customer is a community neurosurgeon doing eight DBS cases a year, they're probably not going first.

They're going to wait until someone at a major academic center has already used it, spoken about it, published on it, and made everyone else comfortable.

That's how clinical adoption works.

Influence flows downhill.

So occasionally the smartest commercial decision is targeting an account that isn't your ideal customer at all.

Not because they're going to generate the most revenue. Because they're going to generate the most credibility.

Those are two very different things.

Choose lighthouse accounts intentionally.

Know exactly what job each account is supposed to do.

• Revenue.

• Clinical evidence.

• Referenceability.

• Peer influence.

Pick the one you need most right now.

Hospital Sales Are Not SaaS Sales

This should not need to be said.

Unfortunately, it does.

Hospital buying processes are not neat little funnels.

You don't move from awareness to demo to contract like you're selling project management software.

You can win the surgeon and lose procurement.

Win procurement and get stuck in IT.

Clear IT and miss budget season.

Hit the next budget cycle and discover your physician champion took a job somewhere else.

Back to the beginning.

Healthcare buying is messy because healthcare is messy.

Your commercial infrastructure has to reflect reality.

Not PowerPoint.

That means tracking multiple stakeholders inside every account.

Understanding budget cycles.

Understanding committee approvals.

Understanding who actually has influence and who merely attends meetings.

If your GTM process assumes a straight line, the hospital purchasing process will eventually introduce it to violence.

Stop Running Your Commercial Operation Out Of A Spreadsheet

I know. Everybody starts there.

A shared Excel file. Twenty-seven tabs. Three versions floating around email.

One person who somehow knows where everything is.

It's manageable until it isn't.

Early on, a structured deal tracker is fine.

You don't need Salesforce while you're talking to five hospitals.

But eventually spreadsheets become the bottleneck.

• You lose visibility.

• You lose accountability.

• You lose context.

And every investor update turns into a late-night archaeological dig through disconnected notes and emails.

At some point you need a real CRM.

Not because CRMs are exciting.

Nobody has ever said, "I can't wait to spend my afternoon updating Salesforce."

You need one because commercial infrastructure becomes more valuable as complexity increases.

Use something your team will actually use.

• Track accounts.

• Track contacts.

• Track deal progression.

• Track engagement.

And make sure everyone can see what happened in the last customer interaction.

Nothing makes a company look disorganized faster than having two employees show up to the same account telling two different stories.

Hospitals notice.

Pricing Is Not A Finance Exercise

Your price tells the market what you think you're worth.

That's why pricing isn't really a finance decision.

It's a positioning decision.

The mistake I see constantly is founders protecting list price like it's family heirloom jewelry.

Meanwhile they have zero customers.

I'd rather see five reference accounts at a steep discount than zero accounts at full price.

Every time.

Those first customers give you something you can't buy:

• Real-world data.

• Clinical champions.

• Testimonials.

• Publications.

• References.

• Credibility.

• The foundation of future revenue.

That doesn't mean pricing should be random.

You still need a clear rationale behind your list price.

You need to understand your value. You need to understand what you're giving away when you discount.

And you need a path back to full commercial pricing.

Because eventually the discounting stops.

And if customers never understood the real value in the first place, that conversation gets awkward very quickly.

Alignment Isn't A Soft Skill

One of the fastest ways to kill a deal is having marketing, sales, and clinical teams tell three slightly different stories.

Hospitals are filled with intelligent people whose entire job is identifying risk.

Conflicting messages look like risk. A surgeon hears one thing. Procurement hears another. Marketing materials say something different.

Suddenly a deal that felt close needs three more meetings.

Your entire customer-facing team should be operating from the same value narrative.

Not memorized. Understood.

Sales should know what clinical is saying.

Clinical should know what sales already promised.

Marketing should reflect reality instead of a positioning workshop from six months ago.

None of this happens by accident.

Someone has to build the system.

And someone has to enforce it.

The Bottom Line

Commercialization isn't a sales hire.

It isn't a CRM.

It isn't a pricing sheet.

It isn't a logo.

It's the operating system that connects all of those things together.

Without it, even great technology gets trapped in long sales cycles, inconsistent messaging, and commercial chaos.

With it, momentum compounds.

Deals become predictable.

Customers become references.

Revenue becomes scalable.

You cannot improvise your way into the U.S. hospital market.

Trust me.

Thousands of founders have already run that experiment for you.

Next week: Step 6. Commercial and Account Segmentation. The part where we talk about who you should actually be selling to first, and why "anyone who will take a meeting" is not a segmentation strategy.

Want to know where your GTM infrastructure actually stands?

👉 Take the U.S. Commercial Readiness Self-Assessment to see how prepared you are.

Curious about the other 11 steps to recovering your medtech business? Click here to learn more!

About the author

Robert Law is the founder of Metamorph MedTech, a go-to-market consulting practice built for medical device and healthcare AI companies that have cleared the FDA and now have to figure out what comes next. With a Kellogg MBA and hands-on experience across surgical robotics, implantable devices, and AI-powered platforms, Robert works in the space where great technology meets commercial reality: health economics, hospital sales strategy, VAC navigation, reimbursement positioning, and the kind of go-to-market infrastructure that turns pilots into revenue. He started Metamorph because too many good technologies were losing to bad commercial strategies, and that bothered him more than he could ignore. Learn more here.